DAA419 |
cadherin 5, type 2 (vascular endothelium) |
Molecular |
skeletal muscle |
Human |
CDH5 |
6.0% Decrease Gene Expression Level |
|
DAA443 |
carbonic anhydrase IV |
Molecular |
skeletal muscle |
Human |
CA4 |
6.0% Decrease Gene Expression Level |
|
DAA346 |
CCAAT/enhancer binding protein (C/EBP), alpha |
Molecular |
skeletal muscle |
Human |
CEBPA |
28.0% Increase Gene Expression Level |
|
DAA529 |
CCAAT/enhancer binding protein (C/EBP), beta |
Molecular |
skeletal muscle |
Human |
CEBPB |
3.0% Increase Gene Expression Level |
|
DAA469 |
CD207 molecule, langerin |
Molecular |
skeletal muscle |
Human |
CD207 |
7.0% Decrease Gene Expression Level |
|
DAA408 |
CDC42 effector protein (Rho GTPase binding) 3 |
Molecular |
skeletal muscle |
Human |
CDC42EP3 |
6.0% Increase Gene Expression Level |
|
DAA462 |
CDK5 regulatory subunit associated protein 3 |
Molecular |
skeletal muscle |
Human |
CDK5RAP3 |
4.0% Increase Gene Expression Level |
|
DAA557 |
centromere protein V |
Molecular |
skeletal muscle |
Human |
CENPV |
4.0% Decrease Gene Expression Level |
|
DAA349 |
centrosomal protein 350kDa |
Molecular |
skeletal muscle |
Human |
CEP350 |
4.0% Increase Gene Expression Level |
|
DAA305 |
chemokine-like factor |
Molecular |
skeletal muscle |
Human |
CKLF |
4.0% Increase Gene Expression Level |
|
DAA448 |
chromatin modifying protein 2A |
Molecular |
skeletal muscle |
Human |
CHMP2A |
3.0% Increase Gene Expression Level |
|
DAA364 |
chromobox homolog 7 |
Molecular |
skeletal muscle |
Human |
CBX7 |
4.0% Increase Gene Expression Level |
|
DAA478 |
chromosome 11 open reading frame 73 |
Molecular |
skeletal muscle |
Human |
C11orf73 |
3.0% Decrease Gene Expression Level |
|
DAA309 |
chromosome 14 open reading frame 2 |
Molecular |
skeletal muscle |
Human |
C14orf2 |
2.0% Decrease Gene Expression Level |
|
DAA504 |
chromosome 16 open reading frame 61 |
Molecular |
skeletal muscle |
Human |
C16orf61 |
4.0% Decrease Gene Expression Level |
|
DAA342 |
chromosome 18 open reading frame 19 |
Molecular |
skeletal muscle |
Human |
C18orf19 |
5.0% Decrease Gene Expression Level |
|
DAA385 |
chromosome 2 open reading frame 88 |
Molecular |
skeletal muscle |
Human |
C2orf88 |
4.0% Decrease Gene Expression Level |
|
DAA480 |
chromosome 4 open reading frame 17 |
Molecular |
skeletal muscle |
Human |
C4orf17 |
13.0% Decrease Gene Expression Level |
|
DAA358 |
chromosome 6 open reading frame 136 |
Molecular |
skeletal muscle |
Human |
C6orf136 |
3.0% Decrease Gene Expression Level |
|
DAA404 |
chromosome 7 open reading frame 44 |
Molecular |
skeletal muscle |
Human |
C7orf44 |
4.0% Decrease Gene Expression Level |
|
DAA506 |
chromosome 9 open reading frame 123 |
Molecular |
skeletal muscle |
Human |
C9orf123 |
2.0% Decrease Gene Expression Level |
|
DAA552 |
chromosome X open reading frame 57 |
Molecular |
skeletal muscle |
Human |
CXorf57 |
35.0% Increase Gene Expression Level |
|
DAA426 |
citrate lyase beta like |
Molecular |
skeletal muscle |
Human |
CLYBL |
6.0% Decrease Gene Expression Level |
|
DAA379 |
coenzyme Q9 homolog (S. cerevisiae) |
Molecular |
skeletal muscle |
Human |
COQ9 |
4.0% Decrease Gene Expression Level |
|
DAA507 |
coiled-coil domain containing 72 |
Molecular |
skeletal muscle |
Human |
CCDC72 |
2.0% Increase Gene Expression Level |
|